Compare HCM & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HCM | BBT |
|---|---|---|
| Founded | 2000 | 1846 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2015 | 2000 |
| Metric | HCM | BBT |
|---|---|---|
| Price | $13.27 | $30.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $20.59 | ★ $35.00 |
| AVG Volume (30 Days) | 37.8K | ★ 938.9K |
| Earning Date | 07-30-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $400,000,000.00 |
| Revenue This Year | $14.24 | $59.75 |
| Revenue Next Year | $11.52 | $3.69 |
| P/E Ratio | ★ $5.49 | $23.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.77 | $24.06 |
| 52 Week High | $16.33 | $32.83 |
| Indicator | HCM | BBT |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 65.12 |
| Support Level | $13.00 | $30.30 |
| Resistance Level | $15.10 | $30.97 |
| Average True Range (ATR) | 0.36 | 0.77 |
| MACD | -0.14 | 0.42 |
| Stochastic Oscillator | 3.85 | 86.83 |
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.